Ligand · BW2
BW2 · N-(4-{[(2-amino-4-oxo-3,4-dihydroquinazolin-6-yl)amino]sulfonyl}benzoyl)glutamic acid
BW2, N-(4-{[(2-amino-4-oxo-3,4-dihydroquinazolin-6-yl)amino]sulfonyl}benzoyl)glutamic acid (C20 H19 N5 O8 S, 489.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within…
- Component
- BW2
- Formula
- C20 H19 N5 O8 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
BW2 in 2 structures; the first of them:
- 1PL0 · Crystal structure of human ATIC in complex with folate-based inhibitor, BW2315U89UC · BW2 B802 · binds LYS266, HIS267, MET312, PHE315, GLY316, ASN489, ASN431, GLN449 and 8 more
- 1PL0 · Crystal structure of human atic in complex with folate- based inhibitor, BW2315U89UC · BW2 B802 · binds LYS266, HIS267, MET312, PHE315, GLY316, ASN489, ASN431, GLN449 and 8 more
Residues it binds most
ASN 4, PHE 4, ASP 4, SER 4, ARG 4, GLN 4, GLY 4, HIS 4, ILE 4, LYS 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.